A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
May 2019
|
| In: |
British journal of haematology
Year: 2019, Volume: 185, Issue: 3, Pages: 583-587 |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.15563 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1111/bjh.15563 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15563 
|
| Author Notes: | Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662827520 | ||
| 003 | DE-627 | ||
| 005 | 20240930114000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190404s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.15563 |2 doi | |
| 035 | |a (DE-627)1662827520 | ||
| 035 | |a (DE-599)KXP1662827520 | ||
| 035 | |a (OCoLC)1341206624 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Döhner, Hartmut |d 1957- |e VerfasserIn |0 (DE-588)110666585 |0 (DE-627)729880842 |0 (DE-576)375358846 |4 aut | |
| 245 | 1 | 2 | |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia |c Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann |
| 264 | 1 | |c May 2019 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 19 November 2018 | ||
| 500 | |a Gesehen am 04.04.2019 | ||
| 650 | 4 | |a acute myeloid leukaemia | |
| 650 | 4 | |a Aurora B kinase | |
| 650 | 4 | |a BI 811283 | |
| 650 | 4 | |a low-dose cytarabine | |
| 650 | 4 | |a phase I | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Lübbert, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fiedler, Walter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 700 | 1 | |a Westermann, Jörg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bug, Gesine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 700 | 1 | |a Krug, Utz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goeldner, Rainer-Georg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hilbert, James |e VerfasserIn |4 aut | |
| 700 | 1 | |a Taube, Tillmann |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ottmann, Oliver G. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d Oxford [u.a.] : Wiley-Blackwell, 1955 |g 185(2019), 3, Seite 583-587 |h Online-Ressource |w (DE-627)269758941 |w (DE-600)1475751-5 |w (DE-576)09113997X |x 1365-2141 |7 nnas |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia |
| 773 | 1 | 8 | |g volume:185 |g year:2019 |g number:3 |g pages:583-587 |g extent:5 |a A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia |
| 856 | 4 | 0 | |u https://doi.org/10.1111/bjh.15563 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15563 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190404 | ||
| 993 | |a Editorial | ||
| 994 | |a 2018 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 910000 |d 910100 |e 910000PK1067780025 |e 910100PK1067780025 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1662827520 |e 3418114431 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Hartmut Döhner, Carsten Müller‐Tidow, Michael Lübbert, Walter Fiedler, Alwin Krämer, Jörg Westermann, Gesine Bug, Richard F. Schlenk, Utz Krug, Rainer-Georg Goeldner, James Hilbert, Tillmann Taube, Oliver G. Ottmann"]},"recId":"1662827520","note":["Veröffentlicht: 19 November 2018","Gesehen am 04.04.2019"],"id":{"eki":["1662827520"],"doi":["10.1111/bjh.15563"]},"title":[{"title_sort":"phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia","title":"A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia"}],"relHost":[{"corporate":[{"role":"isb","display":"British Society for Haematology"},{"role":"isb","display":"European Hematology Association"}],"id":{"issn":["1365-2141"],"doi":["10.1111/(ISSN)1365-2141"],"eki":["269758941"],"zdb":["1475751-5"]},"note":["Gesehen am 08.05.08"],"recId":"269758941","name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"185(2019), 3, Seite 583-587","issue":"3","pages":"583-587","volume":"185","year":"2019","extent":"5"},"language":["eng"],"origin":[{"dateIssuedDisp":"1955-","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","dateIssuedKey":"1955","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"pubHistory":["1.1955 -"],"disp":"A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemiaBritish journal of haematology","title":[{"title_sort":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology","title":"British journal of haematology"}]}],"person":[{"display":"Döhner, Hartmut","given":"Hartmut","role":"aut","family":"Döhner"},{"role":"aut","family":"Müller-Tidow","given":"Carsten","display":"Müller-Tidow, Carsten"},{"role":"aut","family":"Lübbert","given":"Michael","display":"Lübbert, Michael"},{"given":"Walter","display":"Fiedler, Walter","role":"aut","family":"Fiedler"},{"family":"Krämer","role":"aut","given":"Alwin","display":"Krämer, Alwin"},{"role":"aut","family":"Westermann","given":"Jörg","display":"Westermann, Jörg"},{"given":"Gesine","display":"Bug, Gesine","family":"Bug","role":"aut"},{"given":"Richard Friedrich","display":"Schlenk, Richard Friedrich","role":"aut","family":"Schlenk"},{"display":"Krug, Utz","given":"Utz","role":"aut","family":"Krug"},{"given":"Rainer-Georg","display":"Goeldner, Rainer-Georg","family":"Goeldner","role":"aut"},{"family":"Hilbert","role":"aut","given":"James","display":"Hilbert, James"},{"family":"Taube","role":"aut","display":"Taube, Tillmann","given":"Tillmann"},{"given":"Oliver G.","display":"Ottmann, Oliver G.","family":"Ottmann","role":"aut"}],"origin":[{"dateIssuedDisp":"May 2019","dateIssuedKey":"2019"}],"language":["eng"],"physDesc":[{"extent":"5 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a DOEHNERHARPHASEITRIA2019 | ||